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Iron is an essential element for the living organisms but free iron can be toxic. Iron 
levels in the body are tightly regulated. Any fluctuations in the iron levels are an early 
diagnostic indicator of metabolism disorders. Iron metabolism disorders affect a large 
portion of human population. Hence, there exists a need to measure iron in the body 
to diagnose potential iron metabolism disorders. There exists no international 
consensus for measurement techniques and reference values for body iron stores. 
Therefore, there is a need for development of a reference technique to measure body 
iron stores. 
Serum ferritin is widely used as a method to determine body iron stores. However, 
due to poor specificity of immunochemical techniques, ferritin concentration is often 
not accurately determined. Also, as ferritin is a an acute phase protein, its levels rise 
during inflammation and this can result in incorrect measurements. The filling grade 
of ferritin varies and thus, ferritin bound iron is a better measure of body iron stores. 
The ideal technique for determination of body iron stores would measure ferritin 
concentration along with ferritin iron saturation. 
This study uses the principle of Isotope Dilution Mass Spectrometry (IDMS) to 
measure serum ferritin bound iron. IDMS requires the biosynthesis of a ferritin spike 
with isotopically enriched iron and sulphur. IDMS is considered as a definite method, 
as all sources of uncertainty in the analysis can be identified and quantified. 
Therefore, IDMS has been chosen as a reference technique for elemental speciation in 
this study. IDMS involves addition of an isotopically enriched spike of the element to 
be determined to be added after purification of the protein of interest. Elements in the 
isolated biomolecule are quantified by measuring induced changes in isotopic 
VIII 
 
composition of the element by mass spectrometry. In species specific IDMS, any 
physical or chemical loss during analysis does not affect the accuracy of the result, 
once complete mixing of the element species to be analysed and the isotopically 
tagged biomolecule has been achieved. However, the production of the spike, the 
isotopically enriched biomolecule, represents a major challenge.  
The aim of this project was to synthesize a ferritin spike for serum ferritin and ferritin 
bound iron quantification for development of a refernce technique to determine body 
iron stores. This study involved the biosynthesis of a ferritin spike labelled with 
isotopic iron and sulphur. Experiments were performed to determine optimal 
conditions for maximal ferritin overexpression and iron uptake in ferritin. 0.2mM was 
confirmed to be the ideal iron concentration for optimal iron uptake. Iron uptake was 
maximal at 10% under low aeration conditions. This study built upon the previous 
study by labelling the ferritin with isotopic iron and isotopic sulphur thus, 
synthesiszing a double labelled ferritin.  
This double isotopically labelled ferritin spike can be used for development of a 
reference technique for measurement of body iron stores by quantification of ferritin 
bound iron by Thermal Ionization Mass Spectrometry and quantification of ferritin 
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1.1 Human iron metabolism  
1.1.1 Chemistry of Iron 
Iron is the second most abundant metal on earth. It can exist in oxidation states 
ranging from Fe (-II) to Fe (VIII), though it principally exists in two oxidation states - 
Fe (II) and Fe (III).  Oxidation–reduction, hydrolysis and polynuclear complex 
formation are the three types of reactions that account for the biological functions of 
iron and the iron metabolism problems that arise thereof (Aisen, Enns & Wessling-
Resnick, 2001). Iron in aqueous solutions is mainly found in two oxidation states – Fe 
(II) and Fe (III). The electron transfer between these two states is facile and this trait 
is modified by a variety of biological molecules for electron transport (Harrison & 
Arosio, 1996). Iron’s redox capacities make it potentially toxic as it can result in 
reduction of dioxygen, which leads to the Haber-Weiss-Fenton reaction, ultimately 
leading to generation of hydroxyl radicals and which can cause lipid peroxidation, 
DNA strand breaks, and degradation of other biomolecules (Aisen, Enns & Wessling-
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Consequently, free iron concentrations in living organisms are kept low at less than 
10
-18
 M of Fe (III) and about 10
-8




Despite its high abundance, iron is poorly bioavailable due to its limited solubility at 
physiological pH and oxidising conditions. In acidic solutions, iron exists as a  
hexaaquo complex, [Fe(H2O)6]
2+
 which when oxidised to [Fe(H2O)6]
3+  
which is 
insoluble at physiological pH(Crichton & Declercq, 2010). As the pH increases, a 
series of hydrolytic deprotonations result in insoluble ferric polynuclears. Insolubility 
of ferric hydroxide also enhances autoxidation of Fe (II) by mass action. Thus, 
biomolecules have evolved to maintain iron in soluble form. Hydroxide complexes of 
iron polymerize by dehydration to form polynuclear complexes. Organisms have 
utilized this property of iron in several molecules like ferritin and ribonucleotide 
reductase. Cellular iron deficiency is known to cause cell death. Cells and organisms 
have therefore evolved highly sophisticated mechanisms to utilise iron, maintain iron 
in soluble state and minimize the risk of iron toxicity.  
1.1.2 Physiological importance of iron 
Virtually all organisms from Archae to human are dependent on iron for survival.  
The human body contains about 3-5 g of iron. The greatest portion of body iron, about 
60-70%, is distributed in the haemoglobin of red blood cells and developing erythroid 
cells (Andrews, 1999). About 10-20% of body iron is stored the liver which serves as 
the iron storage pool – ferritin and its degradation product homosiderin and in 
reticuloendothelial macrophages (Papanikolaou & Pantopoulos, 2005). The remainder 
8% of the iron is found in myoglobins, cytochromes and other iron containing 





Figure 1.1 Iron absorption, transport, and storage in the human (from 
(Andrews, 2000)). A schematic diagram showing the distribution of iron in 
various tissues in the human body. 
 
As reflected in the distribution of body iron (Figure 1.1), the most prominent role of 
iron in the human body is that of oxygen transport and storage through haemoglobin 
and myoglobin molecules. Haemoglobin is composed of four subunits. Each subunit 
consists of a globin chain and a non-protein part; haeme group composed of a 
protoporphyrin IX ring with Fe (II) embedded as the central atom (Perutz, 1979). The 
molecular properties of haemoglobin and the physicochemical conditions under which 
it operates allow it to bind reversibly to oxygen and deliver it to tissues. Myoglobin, 
structurally similar to haemoglobin but having only one globin chain and one haeme 
unit, is found in the muscles and is mainly involved in oxygen transport and storage in 




Several iron-containing enzymes, the cytochromes have a haeme group with bound 
iron, which enables them to perform oxidation and reduction. Cytochromes act as 
electron carriers in the cell and are involved in oxidative phosphorylation and 
generation of cellular energy in the form of adenosine triphosphate (ATP). Other 
enzymes of the cytochrome family are involved in oxidative degradation of drugs and 
endogenous substrates (cytochrome P450) or providing energy for protein synthesis 
(cytochrome b5). Another group of iron containing proteins are the iron sulphur 
enzymes like nicotinamide adenine dinucleotide dehydrogenase (NADH) and 
succinate dehydrogenase are also involved in electron transport (Beard, 2001). Many 
other enzymes like catalases, ribonucleotide reductase and peroxidases require iron as 
a cofactor or activator. 
The limited bioavailability of iron due to its poor solubility may have resulted in an 
evolutionary pressure against the development of specific mechanisms for iron 
secretion (Andrews & Schmidt, 2007). Hence, the amount of body iron is controlled 
by the rate of its absorption by duodenal enterocytes. Adult humans absorb 1–2 mg of 
iron from the diet to compensate for non-specific iron losses daily. 
1.1.3 Iron absorption 
The proximal small intestine, primarily the duodenum, is the major site for controlling 
iron uptake across the intestinal villus and release of iron to circulation across the 
basolateral membrane. The duodenal enterocytes lining the absorptive villi absorb 
iron. Dietary iron may be in the form of haeme or non haeme and the mechanism of 
absorption varies between haeme and non haeme iron across the intestinal brush 




exists as ferric iron. As ferric iron is insoluble at pH above 3, it must be reduced or 
chelated by amino acids or sugars to be absorbed (Conrad, Umbreit & Moore, 1999). 
Most ferrous iron remains soluble at pH = 7 and hence absorption of iron in ferrous 
form is more efficient (Conrad, Weintraub, Sears & Crosby, 1966). Reduction of 
ferric iron is mediated by cytochrome b-like ferrireductase (DCYTB), a haemoprotein 
associated with the apical enterocyte membrane (McKie et al., 2001). In vitro 
experiments Caco-2 cells (an in vitro human intestinal model system) showed that 
DCYTB actually stimulated iron uptake (Latunde-Dada, Simpson & McKie, 2008). 
There may be other duodenal ferric reductases might interact with ferric iron 
(Andrews & Schmidt, 2007). Once iron is in the reduced ferrous form, it is 
transported across the apical membrane into the absorptive cells (enterocytes) by the 
divalent metal transporter 1 (DMT1, also known as DCT1 or Nramp2). It acts as a 
proton coupled divalent cation transporter and requires low pH for efficient metal 
transport (Fleming et al., 1997; Gunshin et al., 1997). DMT1 is capable of 















. Microcytic anaemic mice and Belgrade rats are defective in intestinal 
iron absorption and consequently anaemic due to mutations in DMT1 gene which 
demonstrates the importance of iron DMT1 in iron (Gunshin et al., 1997; Fleming et 
al., 1997). Alternatively, ferric iron may be absorbed by the paraferritin pathway. 
Paraferritin is a 520 kDa membrane complex consisting of b-integrin, mobilferrin 
(Umbreit, Conrad, Moore, Desai & Turrens, 1996; Conrad, Umbreit & Moore, 1999). 
However, this pathway is less efficient and the exact mechanism is still undefined. 
Another source of dietary iron is haeme, which is liberated by the proteolytic 




lumen (Dunn, Suryo Rahmanto & Richardson, 2007).  Haemoglobin iron is absorbed 
more efficiently than inorganic iron (Majuri & Gräsbeck, 1987). The intact haeme 
molecule enters the enterocyte by a haeme-specific pathway via the haeme carrier 
protein (HCP1) (Shayeghi et al., 2005). Inside the enterocyte, haeme is degraded by 
haeme oxygenase and inorganic iron is released (Oates & West, 2006). This iron is 
either stored in ferritin or enters circulation by basolateral transfer. The iron in ferritin 
is potentially lost due to epithelial sloughing and is an important mechanism for iron 
loss from the human body. Iron for use in the body crosses the basolateral membrane 
by the membrane protein ferroportin 1 (FPN1; also known as SCLC40A1, IREG1, 
and MTP1) (McKie et al., 2001; Abboud & Haile, 2000), which works in conjunction 
















 by ascorbic acid and apical membrane ferrireductases that include the 
duodenal cytochrome B (DCYTB). At the apical membrane, the acid microclimate 
provides an H+ electrochemical gradient that drives Fe2+ transport into the enterocyte 
via the divalent metal transporter (DMT1). Haeme can be taken up by the haeme 
carrier protein (HCP), undergoes endocytosis and Fe2+ is liberated within the 
endosome or lyosome. Cytosolic iron is either stored in ferritin or exported through 
basolateral transfer via ferroportin 1, which is coupled to the ferroxidase activity of 
hephaestin. Exported iron is loaded onto transferrin for distribution. Basolateral 
transfer is regulated over hepcidin, which binds to ferroportin1, causing its 
internalization and degradation, and therefore decreasing iron transfer into the blood. 
1.1.4 Iron distribution 
Once iron is exported from the intestinal cells by ferroportin, it is bound to transferrin 
which plays a critical role in transport of iron in plasma. It is an 80 kDa glycoprotein 
which can bind to two ferric atoms in the presence of an anion (Huebers & Finch, 
1987). Affinity of iron to transferring is pH related and iron is released when pH is 
below 6.5. There is a high proportion of apo-transferrin to ensure efficient chelation 
of free iron in plasma (De Domenico, McVey Ward & Kaplan, 2008). Cellular iron 
uptake is mediated by binding of transferrin to transferrin receptors (Figure 1.3). 




iron requiring cells. Transferrin receptor 2 (TfR2) is mainly expressed in hepatocytes 
and in developing erythroid precursor cells (Kawabata et al., 1999). After binding to 
the receptor, the transferrin-transferrin receptor complex is internalized by receptor-
mediated endocytosis through clathrin-coated pits (Hentze, Muckenthaler & Andrews, 
2004). Inside the cells, the endosome is acidified by an ATP-dependent proton pump 
that lowers the luminal pH resulting in conformational changes in transferrin and 
transferrin receptor and iron release. The transferrin bound transferrin receptor is 
recycled back to the cell surface for reuse. At higher pH, apotransferrin dissociates 
from transferrin receptor which is utilized for iron transport. Ferric iron released from 
transferrin is reduced to ferrous iron for transport out of endosome by ferrireductase 
STEAP3 (Ohgami et al., 2005). Iron passes the endosomal membrane and enters the 







Figure 1.3 Schematic representation of the transferrin-TfR cycle for iron uptake 
into cells (from (De Domenico, McVey Ward & Kaplan, 2008)). Transferrin (Tf) 
binds Fe (III). Tf-Fe (III) binds to the transferrin receptor (TfR) on the cell surface 
from where it is internalized by receptor-mediated endocytosis through clathrin-
coated pits. The endosome is acidified to pH 5.5 and Fe(III) is released, reduced to 
Fe(II) by the endosomal reductase STEAP3 and exported to the cytosol by the 
divalent metal transporter 1 (DMT1). The Tf-TfR complex is recycled for further 
endocytosis cycles. 
 
This iron can be utilized for biosynthesis of haeme or non haeme proteins or to be 
stored in a nontoxic manner in ferritin.  
1.1.5 Ferritin and iron storage 
The liver is the major site for iron storage in the body. Excess iron (about 10-20% of 
absorbed iron) in the body is stored in a non-toxic soluble form in the iron storage 




in the liver, bone marrow and spleen (Andrews, 2000). Ferritin is the main iron 
storage protein in the human body. Ferritins are ubiquitously distributed and highly 
conserved proteins found in animals, plants, fungi and bacteria (Chasteen & Harrison, 
1999). Although primary amino acid sequences of ferritins from different species 
have little homology, their three dimensional structure is highly conserved (Arosio & 
Levi, 2002). 
Ferritin is composed of 24 subunits that form a hollow shell with a molecular weight 
of 450 kDa (Figure 1.4).  
 
 
Figure 1.4 Ferritin structure showing the subunits, channels and the cavity (from 
(US National lib of med)). 
 
Ferritin subunits are symmetrically arranged in a rhombic dodecahedral structure with 




(Chasteen & Harrison, 1999). The protein cage prevents other biological molecules in 
the cytosol from reacting with the iron mineral (Harrison & Arosio, 1996).   
 
Figure 1.5   Ribbon diagrams of exterior surface view and interior cavity of 
ferritin (from (Uchida, Kang, Reichhardt, Harlen & Douglas, 2010)). (A) Human 
heavy chain ferritin and (B) Listeria innocua Dps. 
 
The protein hull contains eight channels located at the threefold symmetry axis of 
ferritin where individual iron ions can enter or leave the protein cage (Watt, Hilton & 
Graff, 2010). Iron is generally taken up as Fe2+, which is oxidized to Fe3+ at the 
surface and channelled into the molecule where it is consequently integrated into the 
mineral core. The cavity can store up to 4500 Fe atoms as ferric oxyhydroxy 




Ferritins from some bacteria and archae have only 12 subunits and are involved in 
iron homeostasis and protection from oxidative damage (Zhao et al., 2002). Thus, 
they are also called Dps proteins (DNA protection during starvation).  
Mammalian ferritin is comprised of two classes of subunits that are almost 
structurally identical, but differ in primary sequence. Mammalian ferritin consists of 
two types of subunits heavy (H) and light (L) chains of 21 and 19.5 kDa, respectively.  
The H subunit shows ferroxidase activity, and is known to catalyse the oxidation of 
ferrous iron more rapidly than L-chain and is important for the iron deposition (Levi 
et al., 1988).  Ferritin binds two Fe (II) ions in the ferroxidase center where the Fe (II) 
ions are oxidized by di-oxygen to Fe (III) (Lawson et al., 1989).  The oxidized Fe (III) 
ions migrate out of the ferroxidase center and into the interior of the ferritin cavity 
where ferric iron binds to nucleation sites for mineralization. The L-chain facilitates 
iron hydrolysis and nucleation of the ferritin iron core as it possesses amino acid 
residues known as the nucleation sites that provide ligands for binding Fe (III) ions 
that initiate crystal growth inside ferritin (Santambrogio, Levi, Cozzi, Corsi & Arosio, 
1996). Composition of ferritin with respect to H and L chains varies according to 
tissue. In general, L-rich ferritin is found in the liver and spleen, while H-rich ferritin 
is found in the heart and brain (Harrison & Arosio, 1996).   
The expression of the ferritin subunits is under transcriptional and translational 
regulation (White & Munro, 1988). Ferritin mRNA contains iron response elements 
(IRE) that can increase the translation of ferritin when iron is abundant and vice versa 
(Munro, 1993). Several factors like TNF-α, IL-1β, IGF-1 and haeme can enhance the 
transcription of the ferritin subunits (Rogers et al., 1990). Transcriptional regulation 




adapt to changes in iron bioavailability. When excessive iron accumulates, 
hemosiderin, a degradation product of ferritin, is formed (SHODEN, GABRIO & 
FINCH, 1953). In contrast to ferritin, hemosiderin is water-insoluble which appears to 
result from incomplete lysosomal processing (Crichton & Pierre, 2001).  
Besides iron storage and iron release, ferritin can act as both an anti-oxidant and as a 
pro-oxidant (Arosio, Ingrassia & Cavadini, 2009). Ferritin is involved in 
inflammation, cellular development, neurological development and angiogenesis 
(Wang, Knovich, Coffman, Torti & Torti, 2010; Alkhateeb & Connor, 2010).  
1.1.6 Regulation of iron metabolism 
Iron homeostasis is regulated both on a cellular and a systemic level. Uptake of 
transferrin into cells is regulated by intracellular iron pools which regulate proteins 
involved in iron metabolism at the posttranscriptional level (Owen & Kühn, 1987). 
This regulation is achieved by two iron-regulatory proteins (IRP1 and IRP2) and iron 
responsive elements (IREs) (Figure 1.6). When cytoplasmic iron is low, IRPs are 
activated and bind to iron regulatory element (IRE) sequences in mRNAs of ferritin, 
TfR1, ferroportin and DMT1. Under low iron conditions, the IRPs bind to the 
stemloop structures of IRE and protect the mRNA from degradation, resulting in 
increased transferring (TfR) synthesis and correspondingly increased iron uptake by 
the cell. Under high iron conditions the IRPs do not bind to the IREs and the TfR 
mRNA is not stabilized, resulting in decreased transferrin synthesis and lower uptake 







Figure 1.6 Iron regulation of iron homeostasis (from (Aisen, Enns & Wessling-
Resnick, 2001)). At low intracellular iron levels both IRP1 and IRP2 bind to the stem 
loop IREs iron responsive elements on the 3’ portion of the transferrin receptor 
mRNA and protect the mRNA from degradation. At high intracellular iron 
concentrations IRP1 binds iron, rendering it unable to bind mRNA. IRP2 is oxidized, 
ubiquitinated and degraded via proteasomes. The transferrin receptor mRNA with no 
IRP bound to it is rapidly degraded, resulting in low steady state levels of TfR 
mRNA. Thus, less transferrin receptor is synthesized. At low iron concentrations, 
IRPs bind to the 5’ portion of the ferritin mRNA preventing translation. At high 
intracellular iron levels, the IRPs do not bind, thereby allowing the synthesis of 
ferritin and sequestration of intracellular iron by ferritin.  
 
As humans do not possess any known regulated form of iron excretion, body iron 
homeostasis is controlled through regulation of iron absorption and storage (Hentze, 
Muckenthaler & Andrews, 2004). Intestinal iron absorption is controlled in at least 
three ways. First, recent dietary iron affects absorption called mucosal block. After a 
large oral iron dose, enterocytes become refractive to absorbing additional iron for 
several days, probably due to accumulation of intracellular iron in enterocyte (Stuart 
et al., 2003). Second, the regulatory mechanism called “store regulator” involves 




mechanism, the “erythropoietic regulator,” adjusts intestinal iron absorption in 
response to the demands of erythropoiesis, independent of body iron stores (Finch, 
1994). 
Hepcidin, a circulating peptide hormone is important in systemic iron regulation. 
Hepcidin is a 25 amino acid molecule, primarily produced by the liver is secreted into 
plasma, and cleared by the kidneys.  Hepcidin controls iron levels by interacting 
directly with FPN1 in duodenal enterocytes, macrophages and hepatocytes, resulting 
in internalization and degradation of FPN1 (Nemeth, Roetto, Garozzo, Ganz & 
Camaschella, 2005). This blocks cellular iron export. When iron stores are high, 
hepcidin is produced in the liver and transported to intestine which results in the 
blockage of iron delivery from the plasma via FPN1 degradation. Consequently, 
shedding of enterocytes results in iron loss. When iron stores are low, Hepcidin 
production is suppressed, enabling FPN1 to transfer iron from enterocytes to the 
plasma and thus dietary iron distribution in the body (Nemeth, Roetto, Garozzo, Ganz 
& Camaschella, 2005). 
1.1.7 Iron metabolism disorders in the body 
Under normal physiological conditions, there is a balance between iron absorption, 
iron transport and iron storage in the human body. The equilibrium of iron 
homeostasis in the body may be disturbed by various factors such as dietary iron 
supply, inflammation or genetic defects in the control of body iron metabolism which 
results in either iron deficiency or iron overload disorders. 
Iron overload disorders may typically manifest in two patterns: excessive plasma iron 




hemochromatosis is a genetic disorder caused due to a defective hemochromatosis 
protein (hfe) and has been well characterized.  Hfe encodes a non-classical Major 
Histo Comaptiblity class I (MHC I) molecule which is involved in regulation of 
intestinal iron absorption (Salter-Cid, Brunmark, Peterson & Yang, 2000). Hereditary 
hemochromatosis is characterized by excess absorption of iron and accumulation of 
excess iron in various tissues, ultimately resulting in various conditions like liver 
cirrhosis, cardiomyopathy, diabetes mellitus, arthritis and maybe even death (Bacon, 
1999). It is a very common autosomal disorder in people of Northern European 
descent.  Mutations in other genes may also result in familial hemochromatosis. Other 
genetic mutations such as transferrin receptor 2 (TfR2), T cell receptor (TCR), β 
macroglobulin, hepcidin (HAMP), hemojuvelin (HJV) are also associated with iron 
overload syndromes (Lieu, Heiskala, Peterson & Yang, 2001). 
In contrast to iron overload disorders, iron deficiency (ID) is highly prevalent in 
humans across populations and remains an important public health problem. World 
Health Organization estimates that iron deficiency affects 66-80% of the world’s 
population (WHO 2003). Any condition in which dietary iron intake is insufficient 
relative to the body’s demands will result in iron deficiency. ID and iron deficiency 
anaemia (IDA) may result from the interplay of three risk factors: increased iron 
requirements, limited external supply and increased blood loss. Thus, ID may be a 
result of, increased iron requirements due to growth or pregnancy, limited external 
supply due to inadequate dietary iron, decreased absorption of iron due to atrophic 
gastritis, mucosal atrophy in coeliac disease and chronic inflammatory bowel diseases 




tis) and possibly Helicobacter pylori infection drug interference and increased blood 
loss due to menstruation, chronic parasitosis, tumours, infections or congenital 
malformations. ID is associated with negative health effects like compromised 
immune function, impaired cognitive development, poor temperature regulation, poor 
energy metabolism and work performance (Dallman, 1986; Gasche, Lomer, Cavill & 
Weiss, 2004).  With the importance of iron and existence of many iron metabolism 
disorders in the human body, there exists a need to measure the body iron stores to 
determine if the body iron is within the healthy range. The following section explores 















1.2 Techniques to measure body iron stores 
We examined in the previous section the importance of iron in the human body and its 
metabolism and the need for maintaing iron levels in the body within a certain range, 
as excess or a deficiency of iron leads to a host of disorders in the body. Thus, it is 
imperative to measure the body iron stores for early detection of various iron 
metabolism disorders which would otherwise lead to severe clinical consequences. 
Early diagnosis is essential to minimize harmful effects of iron metabolism disorders. 
Hence, this section examines various techniques available currently to determine iron 
content in the body. Currently there is no full international consensus on the indicators 
to be used for assessing iron status, as each indicator has its own limitations because 
of either poor sensitivity or poor specificity (Dallman, 1986). 
1.2.1 Tissue and organ parameters 
1.2.1.1 Liver biopsy or bone marrow biopsy  
Liver biopsy or bone marrow biopsy are considered the gold standard method for 
assessment of body iron stores as the iron content of these tissues is reflective of body 
iron stores (Carneiro et al., 2005). Liver biopsy was very useful in diagnosis of 
hereditary hemochromatosis before the discovery of the HFE gene mutations. Liver 
biopsy provides histochemical and chemical quantification of iron concentration as 
well as information about organ damage. Hepatic iron concentration exceeding 80 
µmol/g of liver dry weight is consistent with iron overload (Knovich, Storey, 
Coffman, Torti & Torti, 2009). This procedure is not routinely used as it is highly 





1.2.1.2 Superconducting Quantum Interference Device (SQUID)  
Superconducting Quantum Interference Device (SQUID) is a non-invasive procedure 
involving placing of a low field magnet over the liver. The SQUID is predominantly 
determined by the magnetic volume susceptibility of the paramagnetic 
ferritin/hemosiderin iron in the liver in response to an external magnetizing field 
(Canavese et al., 2004). Normal tissue is diamagnetic and has a magnetic 
susceptibility close to that of water Iron atoms modify the magnetic susceptibility and 
the variation of the magnetization is proportional to the amount of iron present. This 
signal is measured by SQUID detector (Carneiro et al., 2005). SQUID is the only non-
invasive method that has been calibrated, validated in comparison to percutaneous 
liver biopsy and used in clinical study yielding results that are quantitatively 
equivalent to the results obtained by chemical analysis of biopsy tissue (Nielsen, 
Engelhardt, Düllmann & Fischer, 2002). This method is non-invasive, sensitive, 
reliable and fast. It is very helpful in identifying patients with advanced iron overload 
as well as patients with low liver iron. SQUID in combination with HFE mutations 
tests is ideal for identification of hereditary hemochromatosis.  Its main disadvantages 
are its cost and lack of availability of the instrument in clinics. 
1.2.1.3 Magnetic Resonance Imaging (MRI) 
Magnetic Resonance Imaging (MRI) is another non-invasive technology that has 
proved effective for measuring liver iron content. The principle of MRI is that the 
presence of iron ions in a sample causes a reduction of MRI signal intensity, which 
correlates with a decrease in T2 relaxation time of the protons. The advantage of 
MRI-technique is the easy availability of the equipment and ability to measure iron 




evaluated by MRI and it is dependent on tissue alterations such as fibrosis and 
inflammation, which are common in patients with iron overload disorders (Angelucci 
et al., 2002). Moreover, quantification of liver iron using MRI requires special 
software, expertise. Also, individual calibration with liver iron concentration data on 
is needed on each MRI system. 
1.2.2 Iron metabolism regulators parameters 
Hepcidin is a circulating peptide which plays a major role in iron homeostasis. It is 
mainly produced in the liver as well as by myeloid cells and by activated splenocytes 
through a precursor protein, prohepcidin (Liu, Duan, Chang, Wang & Qian, 2006).  
Hepcidin reduces the quantity of circulating iron by preventing its exit from the cells, 
especially from enterocytes and macrophages. It binds to ferroportin, in order to limit 
iron egress, inducing its internalization and degradation (Nemeth, Roetto, Garozzo, 
Ganz & Camaschella, 2005). Hepcidin expression is controlled by iron and 
inflammation. Currently there is no reference method for hepcidin measurement. 
Hepcidin levels reported by the various methods vary considerably but analytical 
variance is generally low and similar for all methods (Kroot et al., 2009).  
1.2.3 Erythrocytes parameters 
1.2.3.1 Haemoglobin levels 
Haemoglobin level is a simple test performed often in conjunction with other tests for 
determining body iron levels. The distribution of haemoglobin values is Gaussian in a 
hypothetical healthy population.  Haemoglobin levels below 12 g/dl for women and 
below 13 g/dl for men are considered indicators of anaemia. If haemoglobin is the 




supplement is a good indicator of true iron deficiency anaemia (Borch-Iohnsen, 
1995). The sensitivity of haemoglobin measurements is poor as the values overlap 
between normal persons and iron deficiency. Also, Haemoglobin is reduced at a late 
stage of iron deficiency and thus is a poor indicator of iron status.  High altitude, 
dehydration and smoking lead to increased haemoglobin levels and a variety of 
chronic diseases, acute infections, overhydrations, haemoglobinopathies, folate and 
vitamin B12 deficiency, cause reduced haemoglobin (Borch-Iohnsen, 1995).Also it 
provides no information on iron overload. 
1.2.3.2 Haem Precursor (Free Erythrocyte Protoporphyrin)  
The haem precursor protoporphyrin accumulates with iron deficiency and is a 
sensitive indicator.  Protoporphyrin increases with lead poisoning and also with 
acquired defects in haemoglobin synthesis. The measurement of protoporphyrin is 
simple. 
1.2.3.3 Mean Corpuscular Volume (MCV)  
Microcytosis of erythrocytes is a morphological indicator of iron deficiency appearing 
earlier than reduction in haemoglobin concentration. Low MCV is also caused by 
heterozygous thalassaemia and chronic disease.  In order to measure iron levels in a 
more reliable manner, other parameters like Red cell distribution width (RDW) or 
heterogeneity complements and Percentage of hypochromic red cells are used in 
conjunction with these erythrocyte parameters. Percentage of hypochromic red cells is 
defined as cells with intracellular haemoglobin of b28 g/dl (Druml, Hörl & Stevens, 
1996). 




1.2.4.1 Mean reticulocyte volume   
Mean Reticulocyte Volume (MRV) increases after iron supplementation therapy in 
patients with IDA and decreases with the development of iron deficient erythropoiesis 
and after treatment with vitamin B12 or folate (Oustamanolakis, Koutroubakis & 
Kouroumalis, 2011).  MRV lacks standardization and hence is not widely used. 
1.2.4.2 Reticulocyte haemoglobin concentration  
Reticulocyte haemoglobin concentration is measured in the stained reticulocytes using 
two angle light scatter (Oustamanolakis, Koutroubakis & Kouroumalis, 2011). The 
reference mean value in healthy population is 30.8 pg.  Reticulocyte haemoglobin 
concentration   provides an indirect measure of the functional iron available for new 
red blood cell production over the previous 3–4 days and an early measure of iron 
restricted erythropoiesis in patients receiving erythropoietin therapy. Further studies 
need to be performed to test the validity of his technique. 
Other reticulocytes factors like Immature Reticulocyte Fraction (IRF), red blood cell 
size factor and reticulocyte distribution width are used to determine body iron levels. 
Immature Reticulocyte Fraction (IRF) indicates the less mature subgroup of 
reticulocytes and is an early and sensitive index of erythropoiesis. Red blood cell Size 
Factor (RSF) is the square root of the product of Mean Corpuscular Volume (MCV) 
multiplied by the Mean Reticulocyte Volume (MRV) and maybe a sensitive 
parameter for the study of bone marrow erythropoietic activity.  Reticulocyte 
Distribution Width (RDWR) is a new generation reticulocyte index and can be 
presented as RDWR-CV (Coefficient of Variation) and RDWR-SD (Standard 
Deviation). RDWR-SD is the standard deviation of the retic volume multiplied by the 




RDWR-SD and the retic volume mean (MRV) multiplied by 100 and is expressed as 
percentage (Oustamanolakis, Koutroubakis & Kouroumalis, 2011). 
1.2.5 Iron status parameters 
1.2.5.1 Serum iron concentration 
The content of iron in the human body is about 40–50 mg of iron/kg body weight.  
Serum iron concentrations reflect the balance between the flow of iron into and out of 
the plasma pool. As body iron stores increase, a rise in serum iron concentration is 
observed. Iron in this pool turns over very rapidly and plasma iron levels are subject 
to large and rapid changes. Many factors like circadian rhythm, turnover of the iron in 
the major iron compartments and absorption, menstruation, diseases influence serum 
iron values and hence it is considered an unreliable index (Jacob, Sandstead, Klevay 
& Johnson, 1980). Serum iron concentrations decrease opposite to elevated serum 
ferritin concentrations, suggesting that ferritin suppresses bacterial growth by 
segregation of iron from bacteria. 
1.2.5.2 Transferrin/total iron binding capacity  
Transferrin (TRF) mediates iron exchange between body tissues. In conditions of 
normal iron status, serum TRF is saturated to about one-third of its iron-binding 
capacity. Transferrin saturation (Tsat) is a measurement of the iron content of the 
circulating TRF. Serum TRF is an indicator for ID but is not as useful as the serum 
ferritin level. Transferrin is a reverse acute phase reactant. TRF concentrations 
increase when iron stores are depleted and decrease with iron overload. However, the 
TRF level is not a consistently reliable index, since it is influenced by factors other 




nephrotic syndrome and malnutrition may all reduce the serum TRF concentration, 
while pregnancy and oral contraceptives will increase it (Crichton & Pierre, 2001). 
Total iron binding capacity (TIBC) indicates the maximum amount of iron needed to 
saturate plasma or serum TRF and it varies with changes in serum iron. TIBC 
methods generally overestimate the iron binding capacity of transferring and no 
generic reference values are available.  
1.2.5.3 Soluble transferrin receptors  
Serum iron, in the form of diferric TRF, is delivered to cells via the TRF-to-cell cycle, 
which involves the transferrin receptor (TfR1). The number of transferrin receptors on 
the cell surface controls the flow of transferrin iron into the cells and reflects the 
cellular requirements for iron. sFR increases with tissue iron deficiency. The serum 
transferrin receptor is a sensitive indicator of tissue iron deficiency and provides a 
quantitative measure of total erythropoiesis when iron deficiency is excluded. The 
serum transferrin receptor is elevated with iron deficiency. It is not affected by 
infection and inflammation (Crichton & Pierre, 2001). This method is a very valuable 
tool in iron status determination and suitable for population surveys.  
1.2.5.4 Serum ferritin and serum ferritin iron 
In humans, serum ferritin concentrations are positively correlated with and are an 
indicator of body iron stores and hence routinely used in clinics to measure body iron 
(Orino & Watanabe, 2008). A small fraction of ferritin in equilibrium with stores 
circulates in the plasma; plasma ferritin protein is elevated in the presence of excess 
stores and is decreased with iron deficiency (Herbert et al., 1997)  Ferritin is an acute 




inflammation, liver disease and malignancies (Borch-Iohnsen, 1995). Moreover, the 
relationship between blood serum ferritin concentration and body iron content is 
altered in a complex manner by chelation and vitamin C treatment and the 
relationship between serum ferritin and body iron appears to be different for different 
hematologic conditions (Canavese et al., 2004). Serum ferritin is the best single 
indicator of iron status. A low level is an indication of depleted iron stores while a 
normal to moderately high serum ferritin does not rule out iron deficiency, nor does it 
indicate adequate or elevated iron stores (Nielsen, Engelhardt, Düllmann & Fischer, 
2002). Even though serum ferritin is a frequently measured marker of iron stores, the 
processes by which ferritin enters circulation are not completely known. It is assumed 
that serum ferritin is a result of leakage into the circulation of tissue ferritin (Linder et 
al., 1996). The concentration of serum ferritin is thus determined both by this leakage 
and by its clearance. Hence liver dysfunction or inflammatory conditions may 
influence the clearance and/or the synthesis of ferritin, thereby increasing serum 
ferritin levels due to factors unrelated to iron metabolism. As serum ferritin protein is 
an acute phase reactant, rising with any inflammatory process, quantitated serum 
ferritin measured using antibody to ferritin protein does not reflect iron content of the 
ferritin (Kovesdy, Lee & Kalantar-Zadeh, 2008). Serum ferritin iron has been 
measured using atomic spectrophotometry along with serum ferritin quantification 
using immunochemical methods. 
There is no international consensus on the techniques for measurement of body iron 
stores for diagnosis of iron metabolism disorders. Hence, there is a need for 





1.3 Methodology to determine serum ferritin-iron content and serum ferritin 
concentration. 
Serum ferritin is traditionally quantified by immunochemical techniques. Though all 
ferritins may have similar quaternary structures, they vary in their primary amino acid 
sequence (Harrison & Arosio, 1996). This causes poor antibody specificity and leads 
to cross reactivity. Moreover, immunochemical methods measure only the 
concentration of the ferritin protein hull. As filling grade of serum ferritin varies, it is 
vital to measure accurately serum ferritin iron content along with ferritin 
concentration to determine body iron stores. 
 For these purposes, the principle of isotope dilution mass spectrometry (IDMS) could 
be used to quantify ferritin bound iron and ferritin. Isotopes of an element are the 
elements that have the same atomic number as the element but different mass 
numbers. In IDMS, the sample with a known isotopic composition but an unknown 
quantity of analyte element is mixed with a known quantity of an isotope of the same 
element, called the spike. The spike contains the analyte element in a different 
isotopic composition. IDMS can therefore only be applied to measure elements, 
which have at least two stable or long-lived radioactive isotopes that can be measured 
in a mass spectrometer free of spectral interferences. After mixing the sample and the 
spike, the sample-spike blend has a new isotopic ratio reflecting the initial isotopic 
composition of the sample and the spike. Thus, by measuring the isotope ratio of the 
mixture, the initial amount of the element in the sample can be calculated from the 
induced changes in isotope composition. The IDMS principle for an element 





Figure 1.7 Illustration of the principle of isotope dilution mass spectrometry for 
an element containing two different isotopes (A and B) (from (Rodriguez-
Gonzalez et al. 2005)). 
 
This methodology has several advantages over other semi quantitative methods as a 
reference technique. The first advantage of IDMS is that instrumental instabilities 
such as signal drift or matrix effects will have no influence in the final value for the 
element concentration in the sample. Furthermore, the uncertainty in the concentration 
measurement depends only on the uncertainty in the measurement of the isotope 
ratios, since atomic weights in the sample are known and the mass taken from the 
sample and spike can be gravimetrically determined. In addition, isotope ratios can be 
determined with high accuracy and precision by using a mass spectrometer. Finally, 
once complete isotope equilibration between the sample and spike has been achieved, 
possible sample loss will have no influence on the final result. This is due to the fact 
that the element quantification is based on the measurement of the isotope ratio of the 






























For measuring ferritin bound iron, a known amount of an isotopically enriched ferritin 
spike is added to the sample altering the isotopic ratio. After isolation of ferritin-
bound iron from the spiked sample, the amount of native ferritin-bound iron as well as 
the amount of sulphur in the protein hull can be derived from the induced changes in 
the isotopic composition. This altered isotopic ratio is then measured by spectrometry. 
To make use of this approach, a solution is needed in which the isotopically labelled 
iron is exclusively bound to ferritin iron and the isotopically labelled sulphur is 
exclusively present in sulphur. Ferritin that is isotopically labeled has chemical 
properties almost identical to the native protein, but it can be distinguished because of 
the difference in masses between them. The biosynthesis of the spike represents a 
major challenge for species specific IDMS (Harrington, Vidler, Watts & Hall, 2005). 
The first successful direct isotopic labeling of ferritin in vivo was performed using 
iron-57 in Escherichia coli using a ferritin gene sequence from Phaseolus vulgaris 
(Hoppler, Meile & Walczyk, 2008). The project involving biosynthesis of iron-57 
enriched ferritin focused on biofortification i.e., increasing the micronutrient content 
of food crops either by conventional plant breeding or by genetic engineering, in order 
to improve iron content of the plants to combat iron deficiency anemia. Ferritin was 
chosen as it was considered the most promising target molecule for triggering iron 
accumulation in food crops (Theil, 2004). Lines of transgenic rice and maize, which 
expressed ferritin from Phaseolus vulgaris, had already been developed (Theil, 
Burton & Beard, 1997). The previous study chose Phaseolus vulgaris ferritin as 
P.vulgaris is a potential crop for biofortification (Hoppler, Meile & Walczyk, 2008). 
The present study continues the work of biosynthesis of a ferritin spike for 




principal of IDMS. As initial work for biosynthesis of the ferritin spike was 
performed using P.vulgaris ferritin, the current study continues by working on the 







1.4 Project Rationale and Aims   
There is no standardized reference technique for measurement of body iron stores. 
Usually many methods are used in conjunction to determine iron status as no single 
method can give reliable and accurate results and the values are affected by factors 
other than iron content of the body. Serum ferritin is a widely used technique to 
measure body iron stores and is non-invasive. Immunochemical assays are widely 
used for quantification of ferritin in human serum. However, due to cross reactivity, 
immunochemical techniques do not give an accurate value of protein quantity. 
Moreover, serum ferritin is an acute phase protein and its levels are elevated during 
inflammation and the iron filling grade of ferritin varies during various physiological 
conditions and between phenotypes and genotypes. Thus, to get a complete picture of 
body iron, it is essential to quantify serum ferritin along with serum ferritin iron. 
Isotope Dilution Mass Spectrometry (IDMS) can be used to overcome these 
challenges and measure serum ferritin and serum ferritin bound iron accurately. As 
IDMS requires a ferritin spike, the aim of this project is synthesis and purification of a 
ferritin spike enriched with iron-57 and sulphur-34. This project continues the 
previous work for biosynthesis of a Phaseolus vulgaris ferritin spike enriched with 
iron-57 (Hoppler, Meile & Walczyk, 2008). This double enriched ferritin spike will 
enable development of a reference technique to quantify serum ferritin and ferritin 







2. MATERIALS AND METHODS 
2.1 Materials 
All the reagents for the preparation of the bacterial media were analytical grade 
reagents (certified for analytical applications and with quantified and minimal iron 
content). The clone E. coli/pFPV transformants of strain BL21-CodonPlus (DE3)-
RIPL containing the Complementary DNA of the ferritin gene of Phaseolus vulgaris 
seeds (pfe) was kindly provided by Laboratory of Human Nutrition, ETH, Zurich, 
Switzerland. Isopropyl-b,D-thiogalactoside (IPTG) was purchased from 1
st
 BASE, 
Singapore. HiTrap Q HP Prepacked with Q Sepharose™ (GE Healthcare Life 
Sciences, USA) was used for anion exchange chromatography. Superdex 200 Prep 
grade gel filtration column by GE Healthcare Life Sciences, USA was used for size 
exclusion chromatography. 
57
Fe-enriched iron in elemental form was purchased from 
Chemgas, Boulogne, France. 
34
S-endriched sulphur in elemental form was purchased 
from Trace Sciences International, Ontario, Canada. The measurements of iron were 
performed using Graphite Furnace Atomic Absorption Spectrophotometry (Varian 
AA240Z, Malgrave, Australia). UV–vis spectrophotometry was performed at 600 nm 
for bacterial growth monitoring (Evolution 300, Thermo Scientific, USA). The acids 
used were sub boiled before use. All the containers and glass ware used were acid 
washed with 10% HNO3 and rinsed with ultrapure water (Milli-Q water, 
Millipore,USA). Samples were mineralized using a mixture of HNO3 and H2O2 by 






2.2 Methods  
2.2.1 Preparation of iron salts from elemental iron 
FeCl2 - The Fe metal (about 0.02827g) was dissolved in approximately 200 uL 30% 
HCl and 100uL ultrapure water in an ultrasonication bath. Sodium citrate (1 M) and 
sodium ascorbate (0.1 M) were added to produce a FeCl2 solution of 10 mM (10mM 
being the concentration of iron) which was stable at pH 7. 
FeSO4 - The Fe metal (about 0.02827g) was dissolved in about 5 ml 0.1M H2SO4 or 
200 uL 95% H2SO4 and 100 uL ultrapure water in an ultrasonication bath. Sodium 
citrate (1 M) and sodium ascorbate (0.1 M) were added to produce a FeSO4 solution 
(10 mM), which was stable at pH 7. 
2.2.2 Preparation of ammonium sulphate from elemental sulphur 
81-85 mg elemental sulphur was added directly into the precleaned vessels (cleaned 
with 8 mL 65% nitric acid and 2 mL 30% hydrogen peroxide). Then, 500 μL 
methanol was added to each sulphur containing vessel. The sulphur lumps were 
carefully crushed until a fine suspension is formed and the vessels were placed into 
the drying oven for 20 minutes. The sulphur was resuspended briefly in 100 μL 
Methanol before 6 mL 65% HNO3 and 2 mL 30% H2O2 were added and microwave 








Table 2.1 Microwave digestion program for sulphur digestion  
Time                                         Power                                    Temperature 
3 min                                        700 W                                        95°C 
10 min                                        700 W                                       160°C 
3 min                                        700 W                                       180°C 
60 min                                        700 W                                       180°C 
15 min                                   -                                                           Ventilation 
 
The colourless sulphur solution (sulphate) was heated at 180°C for about 3.5 hours till 
no notable reduction of volume was observed. Then, 300 μL of 30% H2O2 was added 
and heated at 180°C for at 1 hour to ensure oxidation of sulphur from sulphurous acid 
(H2SO3) to sulphuric acid (H2SO4). The solution of concentrated sulphuric acid was 
cooled down before addition of 1 mL of ultrapure water. Then, the sulphuric acid was 
neutralised according to the following equation to pH 7.  
2 NH3+ H2SO4 → (NH4)2SO4 
2.2.3 Bacterial culture conditions for ferritin with iron spike 
E. coli BL21 pPVF clones were cultured at 37°C in a modified M9 (A) medium that 
was prepared from analytical grade reagents without addition of iron. Mg
2+ 
concentration was reduced to 0.5 mM from 2 mM in the original recipe (Sambrooks et 
al). M9 (A) minimal media was prepared by combining 200ml 5X M9 (A), 10ml 
glucose salt solution (A) and 790 ml autoclaved water for one litre of the medium. 
The medium was supplemented with kanamycin sulphate (30 μg mL−1). 
 500 mL of 5X M9 (A), pH=7 was prepared by weighing 32g Na2HPO4, 7.5g 




Glucose salt solution (A) was prepared by weighing 20g D+ glucose (20% glucose), 
1.2324g MgSO4.7H2O (0.5mM Mg
2+
) and 0.152g CaCl2.2H2O in 100 ml water and 
sterilized by 0.22 μM filter. 
The bacteria were cultured in modified M9 (A) medium at 37°C in an incubator. 
Bacterial growth was monitored by UV–vis spectrophotometry at 600 nm. When the 
optical density of 0.6 was reached, iron solution (0.2mM iron concentration) and 
1mM IPTG were added to induce ferritin synthesis. The cells were harvested after 24 
hours by centrifugation and the bacterial pellet was washed three times with buffer A 
(20 mM tris(hydroxymethyl)aminiomethane–HCl, pH 7.4, 1 mM EDTA). 
2.2.4 Bacterial culture conditions for ferritin with iron and sulphur spike 
E. coli BL21 pPVF clones were cultured at 37 °C in a modified M9 medium that was 
prepared from analytical grade reagents without addition of iron. Mg
2+ 
concentration 
was reduced to 0.5 mM from 2 mM in the original recipe. M9 (B) minimal media was 
prepared by combining 200ml 5X M9 (B), 10ml glucose salt solution (B), ammonium 
sulphate pH=7 (2.5mM) and 790 ml autoclaved water for one litre of the medium. The 
medium was supplemented with kanamycin sulphate (30 μg mL−1). 
 500 mL of 5X M9(B), pH=7 was prepared by weighing 32g Na2HPO4, 7.5g KH2PO4, 
1.25g NaCl and 2.5g NH4Cl in 500 ml water after adjusting the pH to 7. Glucose salt 
solution was prepared by addition of 20g D+ glucose (20% glucose), 1.0165g 
MgCl2.6H2O (0.5mM Mg
2+
) and 0.152g CaCl2.2H2O in 100 ml water and filter 
sterilization using 0.22 μM filter. 
The bacteria were cultured in modified M9 (B) medium at 37°C in an incubator. 




optical density of 0.6 was reached, iron solution (0.2mM iron concentration) and 
1mM IPTG were added to induce ferritin synthesis. The cells were harvested after 24 
hours by centrifugation and the bacterial pellet was washed three times with buffer A 
(20 mM tris(hydroxymethyl)aminiomethane–HCl, pH 7.4, 1 mM EDTA). 
2.2.5 Measurement of iron content in the bacteria 
E. coli BL21 pPVF clones were cultured at 37°C in a modified M9 medium according 
to the above protocols. Bacterial growth was monitored by UV–vis spectrophotometry 
at 600 nm. When the optical density of 0.6 was reached, iron solution (0.2mM iron 
concentration) and 1mM IPTG were added to induce ferritin synthesis. The cells were 
harvested after 24 hours by centrifugation and the pellet was washed three times with 
buffer A (20 mM tris(hydroxymethyl)aminiomethane–HCl, pH 7.4, 1 mM EDTA). 
The bacterial pellet was resuspended in buffer A (20mM Tris-Cl pH=7.4 and 1mM 
EDTA) and lysed by sonication and French pressure cell at 120 MPa. The lysate was 
subjected to centrifugation at 20,000g, resulting in the protein remaining in the 
supernatant while the precipitated salt along with cell debris was in the pellet. The 
supernatant was acid mineralized with 30% H2O2 and 65% HNO3.  2 ml 30% H2O2 
and 8 ml 65% HNO3 were added to the supernatant in a clean digestion vessel and 
heated at 220 C for 1.5 hours. The digestion methodested sample was evaporated to 
dryness and the sample was redissolved in 0.1M HNO3. The iron content of the 







2.2.6 Protein purification 
The bacteria were cultured in modified M9 medium  at 37°C in an incubator till an 
optical density of 0.6 was reached and then 0.2mM iron solution and 1mM IPTG were 
added to induce ferritin synthesis. The cells were harvested after 24 hours and the 
bacteria were pelleted. The bacterial pellet was washed three times with buffer A. The 
washed pellet was resuspended in buffer A (20mM Tris-Cl pH=7.4 and 1mM EDTA) 
and lysed using both French pressure cell and sonicator. The lysate was centrifuged at 
20,000g. The supernatant was subjected to heat treatment for 10 minutes at 63°C and 
centrifuged at 20,000g. The supernatant of the heated lysate was subjected to protein 
purification. The supernatant was injected into Fast Protein Liquid Chromatography 
(FPLC) after filtration using a 0.45 μM filter and subjected to anion exchange 
chromatography using Q HP Hi Trap (GE healthcare) column. The column was 
equilibrated with buffer A and proteins were eluted using a linear gradient of 0–0.15 
M NaCl in the buffer. Collected fractions were analysed for ferritin using 12% 
Sodium Dodecyl Sulphate (SDS) and 5% native Polyacrylamide Gel Electrophoresis 
(PAGE). The peaks containing ferritin were further purified by size exclusion 
chromatography using a Sephacryl® S-200 column with buffer B (50 mM phosphate, 
0.15 M NaCl, 1 mM EDTA, pH 7) for elution. Ferritin containing fractions were 
concentrated by ultrafiltration with a molecular weight cut off of 300 kDa(Vivaspin 
300kDa MCWO, Sartorius, Goettingen, Germany). The purity of the isolated 
recombinant ferritin subunits was assessed by 12% SDS-PAGE and intact ferritin was 
monitored by 5% native PAGE. Iron bound to ferritin was detected by Perl’s Prussian 





2.2.7 Perl’s Prussian blue staining for iron 
The minimum quantity of iron required for Perl’s Prussian blue staining of iron is 2 
μg. A staining solution was prepared by mixing 4% K4(Fe(CN)6)  and 4% HCl in the 
ratio of 1:1, just before use. The gel was covered in staining solution for one hour till 








3.1 Confirmation of Phaseolus vulgaris seeds (pfe) ferritin production by E. coli 
BL21 pFPV 
The clone E. coli/pPVF transformants of strain BL21-CodonPlus (DE3)-RIPL 
containing the Complementary DNA of the ferritin gene of Phaseolus vulgaris seeds 
(pfe) was obtained from the Laboratory of Human Nutrition, ETH, Zurich. It was 
cultured in Lysogeny broth (LB media) at 37°C and cultured onto a LB agar plate to 
obtain individual colonies. The colonies were serially cultured in LB medium to test 
purity of the strain and then regrown on LB agar plates. Some of the original cultured 
colonies were used to prepare bacterial stock for long term storage and used 
subsequently for growing the bacteria. The E.coli pFPV clones were cultured in M9 
(A) at 37°C and ferritin synthesis was induced using 1mM IPTG and 0.2mM FeSO4. 
24 hours after induction, the bacterial cells were pelleted and lysed.  Expression of 




Figure 3.1 Native PAGE (5%) of the cell lysate of E.coli  pFPV showing ferritin 
expression. Lane 1- commercial horse spleen ferritin, lane 2- cell lysate of E.coli 
pFPV showing ferritin overexpression as indicated by the arrow. 




Figure 3.1 confirms the overexpression of a fully assembled ferritin from Phaseolus 
vulgaris cloned in E.coli pFPVby the presence of bands.  
After confirmation of overexpression of ferritin in E.coli pFPV experiments were 
performed to evaluate the optimal conditions for ferritin spiked with Fe-57. Various 
conditions were tested to determine the optimal conditions for maximal iron 
saturation in ferritin for further production of ferritin spike. 
3.2. 0.2mM is the optimal iron concentration for iron uptake in ferritin 
The initial tests for determination of optimal iron uptake conditions were performed 
using a commercially available iron salt FeSO4.7H2O. This was to determine the 
optimal iron concentration at which maximal ferritin saturation was obtained. E. coli 
pPVF bacterial cells were cultured at 37°C in a modified M9 (A) medium and ferritin 
synthesis was induced. The cells were harvested after 24 hours and the bacteria are 











Table 3.1 Effect of different iron concentrations in the bacterial growth media on 
iron uptake by the bacteria measured using GFAAS. 
S.D is the standard deviation. % iron uptake is the percentage of the total iron 
measured in the bacteria compared to the total iron given in the bacterial medium. 
From the GFAAS measurements shown in Table 3.1, it was observed that 80% of the 
iron given in the bacterial media was taken up by the bacteria, irrespective of the iron 
concentration, though excess iron would kill the bacteria. FeSO4.7H2O was observed 
precipitating along with the bacterial pellet which led to the hypothesis that the high 
iron uptake values in bacteria even at very high iron concentrations was a result of the 
precipitation of the iron salt with the pellet rather than an indication of iron taken up 
by the bacteria.  
Bacterial lysis was performed to eliminate iron salt precipitation with the pellet. Once 
the bacteria were pelleted after induction as in the previous experiments, the cells 
were lysed and the lysate was centrifuged. The resulting solution had the protein in 
the supernatant while the salt along with cell debris in the precipitate. The supernatant 
was mineralised and analysed using GFAAS (Table 3.2). 
Iron 
concentration  in 
the media (mM) 
Total iron in bacterial 
pellet (μg) 
% iron uptake S.D (of % iron 
uptake) 
0.2 415.18 79.25 2.46 
 
0.4 907.19 78.21 3.14 
0.6 1455.2 86.30 - 




Table 3.2 Effect of different iron concentrations in the bacterial growth media on 
iron uptake by the bacteria with bacteria lysis measured by GFAAS 
 
0.2mM Fe (II) concentration was determined to be the optimal iron concentration for 
maximal ferritin saturation in E.coli. Increasing the iron concentration resulted in 
lower iron uptakes in the bacteria. The optimum iron uptake was determined to be 
21.2 % in M9 (A) medium. 
3.3 Higher aeration results in lower iron uptake  
Once 0.2mM was determined to be the optimal iron concentration using FeSO4.7H2O, 
experiments were done for replicating iron uptake using prepared FeCl2, pH=7. The 
aim was to prepare the iron salt using the Fe-57 which would be used to make the 
ferritin spike. The bacteria were grown in higher aeration conditions for optimal 
growth. 
Various conditions like different iron salts, Fe (II) and Fe (III), lysis method, aeration 




the media (mM) 
Total iron taken 
up in supernatant 
of lysate (μg) 
% iron uptake S.D  
(of % iron uptake) 
0.2 122.45 21.2 5.22 
0.3 151.5 20.05 3.07 




Initial experiments were done by using prepared FeCl2 as the iron source based on 
previous literature. The bacteria were cultured in modified M9 (A) medium at 37°C in 
higher aeration conditions and ferritin synthesis was induced using 0.2mM prepared 
iron salt solution as the iron source. The cells were harvested after 24 hours and the 
bacteria were lysed by sonication. The supernatant was mineralised and analysed 
using GFAAS and iron content of the samples was measured. 
Table 3.3 Effect of 0.2mM prepared FeCl2  on iron uptake using higher aeration 
conditions 
Iron concentration 
in the media (mM) 












Prepared FeCl2 resulted in low iron uptake of 4.21% (Table 3.3) compared to the 
commercial FeSO4.7H2O which gave 21% (Table 3.2). Various conditions were tested 
to determine optimal culture conditions for maximal iron uptake. 
As FeCl2 resulted in lower iron uptake and commercial FeSO4 gave high iron uptakes, 
FeSO4 was prepared as given as the iron source to determine if it would lead to higher 
iron uptake.  The bacteria were cultured in modified M9 (A) medium  at 37°C in an 
higher aeration conditions and ferritin synthesis was induced using 0.2mM prepared 
FeSO4 as the iron source. The cells were harvested after 24 hours and the bacteria 
were lysed by sonication. The supernatant was mineralised and analysed using 





Table 3.4 Effect of 0.2mM prepared FeSO4 on iron uptake in higher aeration 
 
Iron uptake was 3.14% with FeSO4 (Table 3.4) compared to 21% with the commercial 
FeSO4 (Table 3.2). 
As the iron uptake did not exceed 5% using the prepared iron salts, it was 
hypothesized that the iron form could be the source of low iron uptake. The bacteria 
were cultured in modified M9 (A) medium  at 37°C in an higher aeration conditions 
and ferritin synthesis was induced using 0.2mM prepared  Fe (II) and Fe (III) . The 
cells were harvested after 24 hours and the bacteria were lysed by sonication. The 
supernatant was mineralised and analysed using GFAAS and iron content was 
measured. 
Table 3.5 Effect of iron form on iron uptake using higher aeration conditions 
Iron Form Total iron taken 
up (μg) 
% iron uptake Fe conc. 
Fe (II) 24.79 3.28 0.2 
Fe (III) 36.93 5.16 0.2 
 
The results indicated that the iron form Fe (II) or Fe (III) did not affect iron uptake in 
ferritin by bacteria in the given conditions (Table 3.5). 
 
Iron concentration given 
(mM) 
Total iron taken 




S.D (of % iron 
uptake) 








3.4 Lysis method does not affect iron recovery from bacteria 
The method of lysis was tested to determine if lysis method affected the iron uptake in 
the given conditions. The bacteria were cultured in modified M9 (A) medium at 37 °C 
in a higher aeration conditions and ferritin synthesis was induced using 0.2mM 
prepared iron. The cells were harvested after 24 hours and the bacteria were lysed by 
sonication or French pressure cell. The supernatant was acid mineralised and iron 
content was analysed using GFAAS. 
Table 3.6 Effect of lysis method on iron uptake using higher aeration conditions  





(of % iron uptake) 
French pressure cell 0.116 1.04 0.36 
 
Sonication 0.114 1.02 0.62 
 
As the results in Table 3.6 indicate, method of cell lysis had no effect on iron recovery 
or uptake by bacteria and the iron uptake was very low. 
3.5 Optimal iron uptake occurs under low aeration culture conditions 
Earlier experiments using commercially available FeSO4.7H2O resulted in iron 
uptake of 21%. The only major changes in experimental conditions before lowering of 
the iron uptake in E.coli/pFPV were the use of prepared FeCl2/ FeSO4 instead of 
commercially available FeSO4.7H2O and the use of higher aeration conditions for 
bacterial growth. Hence, iron uptake under higher aeration conditions using 
commercial FeSO4.7H2O was tested to determine if it was the cause of lowering of 




higher aeration conditions and ferritin synthesis was induced using 0.2mM prepared 
iron. The cells were harvested after 24 hours and the bacteria were lysed by sonication 
or French pressure cell. The supernatant was acid mineralised and analysed using 
GFAAS. 
Table 3.7 Effect of FeSO4.7H2O as iron source on iron uptake using higher  
aeration conditions 
 
The results in Table 3.7 indicate that using a higher aeration conditions resulted in 
lower iron uptake probably due to higher aeration which may have resulted in 
oxidation of Fe (II) to Fe (III). Clumping of bacterial cells with the salts was also 
observed.  
As the higher aeration conditions was deduced to result in lower iron uptake, iron 
uptake was studied using prepared FeSO4 and FeCl2 while growing the bacteria in 
incubator at 37°C. The bacteria were cultured in modified M9 (A) medium at 37°C in 
an incubator and ferritin synthesis was induced using 0.2mM prepared iron. The cells 
were harvested after 24 hours and the bacteria were lysed and the supernatant was 



















Table 3.8 Effect of using prepared iron salts on iron uptake in lower aeration 
conditions 
Iron concentration given 
(mM) 










FeCl2 0.2mM 7.379 1.66 0.30 
 
Culturing the bacteria only in lower aeration resulted in considerably higher iron 
uptakes of 21.17% when FeSO4 was used but only 1.66% when FeCl2 was used as the 
iron source (Table 3.8). Hence, FeSO4 was used as the iron source.  
As using an incubator for bacterial growth resulted in better iron uptake and FeSO4  
resulted in better iron uptake in the given conditions, the experiments were replicated 
in large scale cultures as large scale production was required for protein purification. 
Iron was given as prepared FeSO4  
Table 3.9 large scale replication of iron uptake experiments 
Iron given 
(mg) 
Total iron taken up in bacteria 
(mg) 
% iron uptake S.D 










3.6 Bacterial growth is unaffected by addition of ammonium sulphate 
After initial tests were done for determining and testing the optimal conditions for 
ferritin spike with iron, further modifications were made to prepare a ferritin double 
spike with Fe-57 and S-34. All the tests were done using salts prepared from 
elemental iron and elemental sulphur. The additional requirement of producing a 
ferritin double spike was that the sole sulphur source in the bacterial medium is the 
sulphur spike, so that all the sulphur taken up in the ferritin protein hull would be     
S-34 to measure protein concentration accurately using IDMS. 
The initial experiments were done to test the various digestion methods and different 
sulphur salts at 2 different concentrations on iron uptake. All the other sulphur salts in 
the media were replaced as preferably, the only sulphur source should be isotopic 
sulphur to be taken up by ferritin. The bacteria are cultured in modified M9 (B) 
medium (for ferritin double spike) with 2 different digestion methods for ammonium 
sulphate preparation from elemental sulphur and 2 different concentrations of 
ammonium sulphate (0.5mM and 2.5 mM) at 37°C in an incubator and their growth 
was monitored using absorbance at 600 nm at different time intervals to check the 







Figure 3.2 Bacterial growth in M9 (B) medium measured using absorbance at 
600 nm depicted by a graph plotting absorbance at 600 nm vs. time (hours). The 
various lines depict the growth curves of cultures having different concentrations of 
ammonium sulphate and ammonium salts made using different microwave digestion 
protocols. 
 
As observed in the Figure 3.2, it can be concluded that bacterial growth was 
unaffected by the method of ammonium sulphate preparation or the concentration of 
ammonium sulphate or replacement of salts in the medium. 
3.7 Iron uptake is an average of 9.27% with 2.5mM ammonium sulphate 
The bacteria were cultured in modified M9 (B) medium (for ferritin double spike) 
with 2 different digestion methods for ammonium sulphate preparation from 
elemental sulphur and 2 different concentrations of ammonium sulphate (0.5mM and 
2.5 mM) at 37°C in an incubator. Once the optical density of 0.6 was reached, ferritin 







































bacteria were harvested and lysed. The supernatant of the lysate was subjected to acid 
mineralization and the iron content was analysed using GFAAS. 
Table 3.10 Effect of different digestion methods, sulphur salts and concentrations 
on iron uptake in bacteria 
 
The iron uptake is not affected by the media modification and is consistently around 
7-9% for different digestion methods, different sulphur salts (sodium and ammonium) 
and 2 different concentrations (0.5 and 2.5 mM) (Table 3.10). 
As the iron uptake was adequate in the small scale culture, large scale replication of 
the previous experiments were performed using 2.5mM ammonium sulphate (to 
ensure enough sulphur is present in the media when ferritin is produced) and 0.2mM 
FeSO4 . 
Table 3.11 Iron uptake in bacteria with large scale replication using 2.5mM 
ammonium sulphate and 0.2mM FeSO4 . 
Iron given 
(mg) 
Total iron taken up in bacteria 
(mg) 
% iron uptake S.D 





 % iron uptake 
M9 (A)  media  18.46 10.78 
M9 (B) Digestion method1; 0.5mM sodium Sulphate 13.00 7.47 
M9 (B) Digestion method 1; 0.5mM ammonium Sulphate 17.86 9.42 
M9 (B) Digestion method 2; 0.5mM sodium Sulphate 14.59 7.53 
M9 (B) Digestion method 2; 0.5mM ammonium Sulphate 15.94 8.35 
M9 (B) Digestion method 1; 2.5mM sodium Sulphate 16.44 8.48 
M9 (B) Digestion method 1; 2.5mM ammonium Sulphate 15.70 8.04 
M9 (B) Digestion method 1; 2.5mM sodium Sulphate 17.81 9.63 




The iron uptake was on an average of 9.27% which showed that the results were 
replicable in large scale cultures (Table 3.11). 
3.8 FeCl2 and FeSO4 give similar iron uptake 
The iron source in the media was iron sulphate which would be a source of non-
isotopic sulphur and would affect sulphur measurements. Hence, different iron salts 
were tested for iron uptakes in bacteria to determine if FeSO4 could be replaced by 
FeCl2 as the iron source in the given culture conditions. The bacteria are cultured in 
modified M9(B) medium  at 37 °C in an incubator till an O.D of 0.6 was reached and 
then 0.2mM iron solution prepared FeSO4  or FeCl2as the iron source and 1mM IPTG 
is added to induce ferritin synthesis. The cells were harvested after 24 hours and 
lysed. The supernatant was acid mineralised and analysed using GFAAS. 
Table 3.12 Iron uptake in bacteria using 2.5mM ammonium sulphate and 
different iron salts. 
 
As shown from the results in Table 3.12, the iron uptake is not affected by the iron 
salt form in M9 (B) modified medium and hence the future experiments were 
performed with FeCl2 to remove other sulphur sources in the medium. 
  
Iron form given % iron uptake S.D 
FeSO4 (Iron dissolved in 0.1M H2SO4) 9.69 1.12 
FeSO4 (Iron dissolved in  conc. H2SO4) 9.03 0.55 




3.9 Initial ferritin purification from lysate using nickel beads to bind his-tag in 
ferritin 
Once iron uptake conditions were optimized, experiments were done to optimize 
protocol for purification of ferritin from E.coli pFPV. Phaseolus vulgaris ferritin was 
cloned using PeT28(a) vector which carries an N-terminal 
His•Tag®/thrombin/T7•Tag® conﬁguration. Hence it was hypothesized that Ni-NTA 
Agarose could be used for purification of ferritin from crude lysate before injection 
into FPLC. The bacteria were cultured in modified M9 medium  at 37 °C in an 
incubator till an O.D of 0.6 is reached and then 0.2mM iron solution and 1mM IPTG 
was added to induce ferritin synthesis. The cells were harvested after 24 hours and 
lysed. The supernatant of the lysate was mixed with Ni-NTA Agarose beads and kept 
on a shaker for 3 hours for binding. The beads were pre washed and equilibrated with 
lysis buffer overnight. The lysate was removed and the beads were washed 3 times 
with buffer containing imidazole 50mM for 30 minutes. The protein was eluted using 
buffer with 500 mM imidazole. The eluate was centrifuged at 10,000g for 10 minutes 
to remove any particles. The supernatant of the eluate is then injected into the 
Superdex - 200 (for size exclusion) column in FPLC. The fractions were collected and 





Figure 3.3 Chromatogram of size exclusion plotted absorbance (UV) vs. time. 
 
A peak for ferritin was not observed after size exclusion chromatography (Figure 3.3). 
A 12% SDS-PAGE was performed to determine in which stage of purification ferritin 
was present. The SDS-PAGE of various steps of purification revealed that ferritin did 
not bind to Ni-NTA Agarose beads. This could probably be due to ferritin being a 
multimer and the tag being hidden within the multimeric protein structure. A literature 
review shows that use of Ni-NTA Agarose beads to purify ferritin is rarely practised. 
3.10 Initial purification of lysate to remove contaminants using heating and 
ultrafiltration 
Injection into FPLC required a certain level of purified protein as injection of a 
complete cell lysate would result in clogging of the column and the filters. As use of 
Ni-NTA Agarose beads did not work, initial purification was performed by heating of 
bacterial lysate supernatant. This was performed after going through literature where 
this method is commonly used to purify serum ferritin and serum ferritin is known to 




The bacteria were cultured in modified M9 medium at 37°C and ferritin synthesis was 
induced. The cells are harvested after 24 hours and lysed. The lysate was subjected to 
heat treatment at 63 C 10 minutes and the supernantant was ultrafiltrated using 
ultrafilters of 300 kDa molecular weight cut off.  
 
Figure 3.4 Native PAGE of heat treated lysate to confirm intact ferritin. Lane 1- 
Commercial Horse Spleen Ferritin, lane 2- Supernatant of heated lysate, lane 3- 
Supernatant of ultafiltration, lane 4- Flow through of ultrafiltration 
 
The presence of bands in Figure 3.4 showed that ferritin was not denatured by heat 
treatment and ultrafiltration of the heated lysate decreased yield of ferritin and hence 
was not performed for future experiments. 
3.11 Heat stability tests on plant ferritin 
A literature search revealed that one of the protocols for one of the protocols for 
purifying serum ferritin is by heating serum, which denatures many contaminating 
proteins.  Very few studies have been done on thermal stability of plant ferritin, 
especially Phaseolus vulgaris ferritin. Heating of cell lysates with ferritin was done at 
various temperatures for determining the ideal temperature to purify the bacterial 
lysate and study thermal stability of Phaseolus vulgaris ferritin. The bacteria were 




cultured in modified M9 medium at 37°C in an incubator and ferritin synthesis was 
induced by 0.2mM iron solution and 1mM IPTG. The cells were harvested after 24 
hours and lysed in buffer A. The supernantant, which contained ferritin, was subjected 
to different temperatures for varying amounts of time. Different lysate samples were 








C respectively for 10 minutes each 









for 15 minutes each. The samples were centrifuged at 10,000g for 10 minutes. The 
supernatant obtained after heat treatment was analysed using PAGE  
 
Figure 3.5 5% Native PAGE of lysate samples heat treated at different 
temperatures and time. Lanes 1 and 2 -Horse spleen ferritin, 3 - Bacterial lysate 
heated at 50°C 10 min, 4 - Bacterial lysate heated at 50°C 15 min. 5 - Bacterial lysate 
heated at 60°C 10 min, 6 - Bacterial lysate heated at 60°C 15 min, 7- Bacterial lysate 
heated at 70°C 10 min, 8 - Bacterial lysate heated at 70°C 15 min, 9-Bacterial lysate 
heated at 80°C 10 min, 10 - Bacterial lysate heated at 80°C 15 min 
 
 





Figure 3.6 12% SDS-PAGE of lysate samples heat treated at different 
temperatures and time. Lanes 1 - Horse spleen ferritin, 2 - Bacterial lysate heated at 
50°C 10 min, 3 - Bacterial lysate heated at 50°C 15 min., 4 - Bacterial lysate heated at 
60°C 10 min, 5 - Bacterial lysate heated at 60°C 15 min, 6- Bacterial lysate heated at 
70°C 10 min, 7 - Bacterial lysate heated at 70°C 15 min, 8-Bacterial lysate heated at 
80°C 10 min, 9 - Bacterial lysate heated at 80°C 15 min 
 
Heating of bacterial lysate at 60°C for 10 or 15 minutes was ideal for removing 
contaminating proteins and to inject into FPLC for anion exchange. The results 
showed that temperatures greater than 70°C resulted in degradation of plant ferritin in 
comparison to animal ferritin which is more heat stable (Figure 3.5 and Figure 3.6).  
3.12 Ferritin purification using anion exchange and size exclusion 
Once the optimal conditions for heat lysis were determined, further purification of 
ferritin was done. The bacteria were cultured in modified M9 medium at 37°C in an 
incubator. Ferritin synthesis was induced by addition of 0.2mM iron and 1mM IPTG. 
The cells are harvested after 24 hours and lysed. The supernatant of the lysate was 
subjected to heat treatment at 63°C for 10 minutes and centrifuged. The supernatant 
was subjected to protein purification by anion exchange and then by size exclusion 
chromatography. 





Figure 3.7 Anion exchange run chromatogram depicting the various fractions on 




Ferritin was found to elute about 60 minutes after injection (Figure 3.7). The fraction 




Figure 3.8 Size exclusion chromatogram showing the various fractions on X axis 
and absorbance at 280 nm on Y axis. Ferritin is the first peak in the chromatogram 




Ferritin weighing around 560 kDa was eluted out in the first peak (Figure 3.8) and 
was confirmed by the presence of ~23 kDa bands in the SDS-PAGE (Figure 3.9) 
which corresponds to the subunits of P.vulgaris ferritin. 
 
Figure 3.9 12% SDS-PAGE of lysate at different stages of purification. Lane 1 – 
Marker, lane   2- Lysate, lane 3 – Heated Lysate, lane 4- 5- Anion exchange. The 




Figure 3.10 5% Native PAGE of the cell lysate of E.coli  pFPV with ferritin 
induction and after purification. Lane 1- horse spleen ferritin, lane 2 - heated cell 
lysate of E.coli  pFPV, lane 3 – ferritin after size exclusion chromatography 
                      1       2          3                   4                      






Figure 3.11 12 % SDS-PAGE of the cell lysate of E.coli BL21 pFPV with ferritin 
induction and progressive purification. Lane 1- commercial marker, lane 2 - cell 
lysate of E.coli  pFPV, lane 3 –heated cell lysate of E.coli  pFPV lane 4 – ferritin after 
size exclusion chromatography. 
 
 
Figure 3.12 5% Native PAGE of purified ferritin from E.coli pFPV for iron 
staining. Lane 1- horse spleen ferritin iron stained with Prussian blue, lane 2 - ferritin 
from E.coli pFPV after size exclusion chromatography stained for iron 
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Ferritin was observed in progressive purification steps by Native and SDS-PAGE 
(Figure 3.10 and Figure 3.11). Iron in ferritin was stained by Prussian blue staining of 
iron (Figure 3.12).  
3.13 Final tests for biosynthesis of ferritin spike under optimal conditions 
The final replication of the results was done using 100 ml cultures and checked for 
iron at every stage from lysis to protein purification fractions. Nine 100 ml cultures of 
bacteria E.coli  pFPV were cultured in modified M9(B) medium and 5 X 100ml were 
cultures in M9 (A)  at 37°C in an incubator and 0.2mM iron solution (FeCl2 for B and 
FeSO4 for A) and 1mM IPTG was  added to induce ferritin synthesis. The cells were 
harvested after 24 hours and lysed using bacterial lysis reagent. The supernatant was 
heat treated at 63°C for 10 minutes .The supernatant of the heat treated lysate were 
treated by a different combination of purification methods and analysed for iron 








Figure 3.13 12% SDS-PAGE of the cell lysate of E.coli  pFPV with ferritin 
induction and after purification. Lane 1- horse spleen ferritin, lane 2,3,4 - cell 




Figure 3.14 5 % Native PAGE of the cell lysate of E.coli  pFPV with ferritin 
induction and after purification. Lane 1- horse spleen ferritin, lane 2,3,4 - cell 
lysate of E.coli  pFPV, lane 5,6,7 – heated lysate, lane 8,9,10 – lysates subjected to 
anion exchange 
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Figure 3.15   5% Native PAGE of the cell lysate of E.coli  pFPV with ferritin 
induction and after purification. Lane 1- horse spleen ferritin, lane 2 to 8 – different 
fractions obtained from anion exchange to determine where ferritin eluted 
 
The presence of ferritin in the samples was assessed by the presence of corresponding 
bands in native and SDS-PAGE (Figure 3.13, Figure 3.14 and Figure 3.15). The 
results showed that iron uptake was considerably lower which could be probably be 
due to use of bacterial lysis reagent. Different combination of methods was tried for 
protein purification and the ideal method for protein purification was determined to be 
anion exchange followed by size exclusion after heat treatment of the lysates at 63°C 
Ultrafiltration of the lysates resulted in loss of the protein and poor recovery of 
ferritin. 






Total iron in 
sample(μg) 
% iron uptake 
Lysate 7.601 46.780 1.40 
Heated lysate Supernatant 6.335 41.676 1.24 
Anion exchange fractions 3.136 21.999 0.66 
Size exclusion 0.701 5.752 0.17 




These experimental results as shown in Table 3.13 showed that ferritin was 
overexpressed in the bacteria but progressive purifications resulted in considerable 
loss of iron bound to ferritin. The reasons for poor recovery of ferritin bound iron 
were attributed to use of bacterial lysis reagent. 
3.14 Biosynthesis of ferritin spike with iron-57 and sulphur-34 
Once the optimization experiments were done, S-34 and Fe-57 stable isotopes were 
used to synthesize the ferritin double spike. Eighteen 100 ml cultures of bacteria 
E.coli  pFPV were cultured in modified M9(B) medium (with S-34) at 37°C in an 
incubator and 0.2mM iron solution (Fe
57
Cl2) and 1mM IPTG was  added to induce 
ferritin synthesis. The cells were harvested after 24 hours and lysed. The supernatant 
was subjected to heat treatment. The heat treated lysates were acid mineralized and 
iron uptake was measure using GFAAS at every stage of purification. The lysates and 
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Figure 3.16 12 % SDSPAGE of the cell lysates of E.coli  pFPV with 
ferritin double spike. Lane 1- Commercial SDS protein marker, lanes 2, 4,6 – 
lysates, lanes 3,5,7 – heated lysates 
 
After confirmation of ferritin expression and with iron uptake at an average of 
11.10%, all the lysate was subjected to anion exchange chromatography.  The 





Figure 3.17 12 % SDS-PAGE of different fractions from 3 different anion 
exchange runs. Lane M - Commercial SDS protein marker, Remaining lanes – 
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Figure 3.18 Anion exchange chromatogram plotted with absorbance vs. Time. 
The red box depicts ferritin elution in the chromatogram. 
 
Ferritin was found to elute out about 60 minutes after injection (Figure 3.18) as 




subjected to acid mineralization and the iron content of the fractions was measured 
using GFAAS. 
Table 3.16 Iron uptake in bacteria and recovery at various stages of purification 
 
Sample 
Total iron in sample 
(mg) 
% iron uptake 
Lysate 2.489 12.52 
Heated lysate Supernatant 2.207 11.11 
Anion exchange fractions 0.027 0.14 
   
 
 
The ferritin bound iron after anion exchange was very low at an average of 0.14% 
(Table 3.16). Thus, the production of ferritin double spike cannot be considered 
successful due to considerable loss of ferritin and ferritin bound iron after protein 
purification. As there was low iron uptake, it had to be determined if it was a result 
iron leaking from ferritin or lack of protein. 
It remains to be determined if the protein purification merely separated ferritin bound 
iron from non ferritin bound iron, indicating that iron is not optimally bound to 
ferritin or theprotein purification results in leakage of iron from the ferritin protein 












A reference technique for accurate measurement of serum ferritin and serum ferritin 
iron is currently lacking. Isotope dilution mass spectrometry is widely considered as a 
reference method providing results with very high precision and accuracy in 
elemental speciation. In its simplest form, an isotopically enriched spike of the 
element to be determined is added after purification of the metalloprotein of interest. 
Endogenous metal in the isolated biomolecules is quantified by measuring the 
induced changes in isotopic composition of the element by mass spectrometry.  
IDMS has several advantages over others methods as a reference which have been 
elaborated in Section 1.3. IDMS will work perfectly as a reference technique only 
when certain criteria are met. These include a homogenous blend of the sample and 
the spike, availability of a certified and quantified spike, handling the mass spectral 
interferences and minimising and quantifying contamination (Heumann, 1992). Also, 
for species specific IDMS, production of the spike presents a major challenge. 
Consequently, only a limited number of species specific IDMS techniques either for 
quantification of metals bound to small biomolecules or more complex 
metalloproteins have been developed.  
One of the first studies that involved biosynthesis and chemical characterization of a 
spike for species specific IDMS was for determination of selenomethionine where 
77
Selenium-enriched selenomethionine spike obtained by yeast growth on a 
77
Selenium-rich culture medium (Hinojosa Reyes et al., 2004). Different methods of 
yeast enrichment with selenium were evaluated to determine the most effective 
conditions for biosynthesis of the selenomethionine spike and to characterize the total 




The first biosynthesis of a complex metalloprotein containing an enriched metal 
isotope for species specific isotope dilution analysis involved the copper-containing 
protein rusticyanin (Rc) from the bacterium Acido-thiobacillus ferrooxidans 
(Harrington, Vidler, Watts & Hall, 2005). Rusticyanin spike was produced using a 
bacterial expression system and the overexpressed protein was purified. The protein 
was cloned into E.coli BL21 and overexpressed and purified by ion exchange 
chromatography. Rusticyanin was enriched with 
65
Cu and different forms of the 
protein were studied using organic and inorganic mass spectrometry. Another study 
for determining transferring in serum using IDMS was performed by synthesizing an 
isotopically enriched standard of saturated transferrin; saturated with 
57
Fe (del Castillo 
Busto, Montes-Bayón & Sanz-Medel, 2006). 
A similar principle of IDMS and biosynthesis of a ferritin spike using iron-57 can be 
used for the quantification of ferritin-bound iron and sulphur-34 for quantification of 
ferritin in biological samples. The initial studies for biosynthesis of the ferritin spike 
were performed for quantification of ferritin bound iron in plants for studying 
biofortification (Hoppler, Zeder & Walczyk, 2009). The present study is on 
biosynthesis of a double labelled spike labelled with isotopically enriched iron and 
sulphur for quantification of both ferritin bound iron as well as ferritin protein in 
serum.  
4.1 Confirmation of the E.coli/pFPV clone 
The E. coli clone pFPV having the Phaseolus vulgaris ferritin gene was confirmed to 
express plant ferritin by both SDS and native PAGE.  The SDS-PAGE showed the 




intact multimer of ferritin. Iron staining showed that the protein indeed was ferritin 
and had ferritin bound iron which was stained by Prussian blue. 
4.2 Optimization of conditions for ferritin to be spiked with iron 
The initial experiments were done to optimize the iron uptake conditions for synthesis 
of ferritin spike with iron. The ideal iron concentration was determined to be 0.2mM 
for optimal saturation of ferritin with iron which confirmed the previous findings. In 
contrast to the previous study, iron sulphate gave much higher uptakes than iron 
chloride in the M9 (A) media. This could probably be a result of higher sulphates in 
the medium when iron sulphate was used as the iron source. 
The factor which affected iron uptake by bacteria the most was determined to be 
aeration of the cultures. Cultures grown in greater aeration had very low iron uptakes 
irrespective of other conditions and the iron uptake remained uniformly low 
irrespective of the iron form or iron salt. Culturing the bacteria in lower aeration 
conditions resulted in considerably higher iron uptakes. 
4.3 Optimization of conditions for ferritin to be spiked with iron and sulphur 
The earlier study involved biosynthesis and characterization of ferritin spike with 
iron-57.  Synthesis of ferritin spiked with iron and sulphur required changing the 
composition of the bacterial media to eliminate all extra sulphur sources and did not 
affect bacterial growth. The bacterial growth was optimal even with excess 
ammonium sulphate (2.5mM) in the medium. The iron uptake in the bacteria 
remained at around 10% for the modified M9 (B) medium. Using iron chloride as the 
iron source (iron concentration = 0.2mM) did not lower the iron uptake as was the 




M9 (A) for bacterial growth and consequent protein expression while sulphur was 
available in the medium due to the addition of 2.5mM ammonium sulphate in M9 (B). 
4.4 Protein purification 
Phaseolus vulgaris seed ferritin gene was cloned into the expression vector pET 28 
(a) which has both N and C terminal his tags. Initial purification of ferritin 
overexpressed in E.coli/pFPV was attempted using Ni-NTA beads which bind to the 
His-tag in protein and result in purification. Purification using his tag did not work 
probably due to the masking of the subunits which combine to form a multimeric 
ferritin.  
 Phaseolus vulgaris ferritin was shown to be thermally stable up to a temperature of 
65°C and temperatures greater than 65 °C lead to progressive degradation of ferritin. 
4.5 Biosynthesis of ferritin spike 
The biosynthesis of ferritin spike enriched with iron-57 inside the protein and sulphur-
34 in the protein hull was unsuccessful. There are several possibilities for the low 
uptake of iron in ferritin. Further experiments need to be performed before concluding 
if ferritin was optimally saturated with iron and purification processes lead to leakage 
of iron or protein purification merely separated ferritin bound iron from non-ferritin 
bound iron. Non ferritin bound iron would still remain in the solution due to the 
presence of EDTA in the lysis buffer. It is also probable that sonication lead to 
disruption of the protein hull and consequent leaching out of iron from inside of the 






This study involved the biosynthesis of a ferritin spike labelled with isotopic iron and 
sulphur and determination of optimal conditions for bacterial growth of E.coli/pFPV  
in M9 media for maximal ferritin overexpression and iron saturation. The results 
suggest that it is possible to have unaffected bacterial growth and iron uptake of 10% 
after introducing 2.5mM ammonium sulphate and with slight modifications to the M9 
minimal media. The factors which affect iron uptake in bacteria include iron 
concentration in the medium, aeration, lysis method, iron form and sulphur 
concentration in the medium. 0.2mM is confirmed to be the ideal iron concentration 
for optimal iron uptake. Lower aeration corresponds to higher iron uptakes in 
E.coli/pFPV. Iron uptake and bacterial growth is higher in the medium in presence of 
excess sulphur  up to 2.5mM. 
Phaseolus vulgaris ferritin cloned in E.coli/pFPV is stable to heat treatment to a 
temperature of 65 C. The protein can be purified by a three stage purification 
involving heat treatment of lysates, anion exchange chromatography followed by size 
exclusion chromatography. 
Quantification of serum ferritin for determining the body iron stores is inaccurate and 
does not provide a good measure of body iron stores as ferritin filling grade varies and 
ferritin is an inflammatory protein. Quantification of ferritin bound iron by TIMS and 
the protein and its utilization for measuring serum ferritin would provide a more 






6. FUTURE WORK 
The main aim of the project was to optimize condition and ultimately produce a 
ferritin enriched with Iron-57 and Sulhur-34, which could be used for isotope dilution 
with serum ferritin and consequently used to determine the protein content of ferritin 
accurately by ICP-MS and ferritin bound iron by TIMS. 
The optimal culture conditions for biosynthesis of the ferritin spike have been 
determined but the recovery of iron in ferritin after protein purification poses a major 
problem. There are three possibilities which result in poor iron recovery from ferritin 
after anion exchange. One, anion exchange chromatography is inefficient and leads to 
major loss of protein. Two,  the ferritin bound iron was low all along and anion 
exchange  chromatography helps in separating EDTA bound iron from ferritin bound 
iron. Three,  lysis of bacteria by sonication leads to leaching out of iron from ferritin. 
To determine if anion exchange chromatography results in protein loss and 
consequently iron loss, recovery of ferritin and iron from anion exchange will be 
determined by subjecting commercial horse spleen ferritin to anion exchange 
chromatography and determining the protein concentration and iron recovery of the 
fractions as a standard and comparing the results with E.coli/pFPV cell lysates that 
have been cultured to overexpress ferritin. 
After subjecting the lysates of E.coli/pFPV to anion exchange, all the fractions will be 
analysed for iron. This will help us in determining, if other forms of iron are present 
in the samples apart from ferritin bound iron.  
To determine if sonication results in leaching out of iron from ferritin, different lysis 




Further work will involve biosynthesis and purification of the ferritin spike with 
optimal ferritin bound iron.  The ferritin spike will be characterized using TIMS for 
iron isotopic ratios and protein hull will be characterized using ICP-MS. 
The characterized ferritin spike will be mixed with purified human serum ferritin 
using Isotope Dilution Mass Spectrometry for determining the serum ferritin 
concentration and serum ferritin bound iron. 
This will lead to development of a novel reference technique for measuring serum 
ferritin and serum ferritin bound iron which would ultimately give a better measure of 
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